How much funding has Seattle Genetics raised?

Seattle Genetics has raised $1.0B in total funding, most recently a Corporate Round.

Who are Seattle Genetics's investors?

Seattle Genetics's investors include Pfizer Ventures, Merck Life Sciences, J.P. Morgan, Baker Brothers Investments.

When was Seattle Genetics founded?

Seattle Genetics was founded in 1998.

Where is Seattle Genetics headquartered?

Seattle Genetics is headquartered in Bothell, Washington, United States.

What industry is Seattle Genetics in?

Seattle Genetics operates in biotechnology, cancer_treatment.

How many employees does Seattle Genetics have?

Seattle Genetics has 1001-5000 employees.

Seattle Genetics

Acquired

Pfizer: One of the world's premier biopharmaceutical companies

Bothell, United States · Founded 1998 · $1.0B raised

biotechnology

cancer_treatment

Headquarters: Bothell, Washington
Employees: 1001–5000
Founded: 1998
Business Model: B2B

Website: seagen.com
Total Funding: $1.0B
Last Round: $1.0B Corporate RoundSep 2020
Rounds: 4

About

Seattle Genetics (later rebranded as Seagen) was a Bothell, Washington-based biotechnology company specializing in developing antibody-drug conjugates (ADCs) for cancer treatment. Founded in 1998, the company pioneered ADC technology, which links cancer-targeting antibodies to potent chemotherapy drugs, enabling precision delivery to tumor cells. Seagen was acquired by Pfizer in December 2023 for approximately $43 billion.

Summary

Seattle Genetics is a biotechnology company based in Bothell, United States, founded in 1998. It has raised $1.0B in total across 4 rounds, most recently a $1.0B Corporate Round round in Sep 2020. Investors include Pfizer Ventures, Merck Life Sciences and J.P. Morgan.

LinkedIn X (Twitter)